Evidence synthesis and guideline development in genomic medicine: current status and future prospects

Autor: Schully, Sheri D., Lam, Tram Kim, Dotson, W. David, Chang, Christine Q., Aronson, Naomi, Birkeland, Marian L., Brewster, Stephanie Jo, Boccia, Stefania, Buchanan, Adam H., Calonge, Ned, Calzone, Kathleen, Djulbegovic, Benjamin, Goddard, Katrina A.B., Klein, Roger D., Klein, Teri E., Lau, Joseph, Long, Rochelle, Lyman, Gary H., Morgan, Rebecca L., Palmer, Christina G.S., Relling, Mary V., Rubinstein, Wendy S., Swen, Jesse J., Terry, Sharon F., Williams, Marc S., Khoury, Muin J.
Zdroj: Genetics in Medicine; January 2015, Vol. 17 Issue: 1 p63-67, 5p
Abstrakt: With the accelerated implementation of genomic medicine, health-care providers will depend heavily on professional guidelines and recommendations. Because genomics affects many diseases across the life span, no single professional group covers the entirety of this rapidly developing field.
Databáze: Supplemental Index